Retinal Changes in Vitamin D Deficiency (VDD)
Primary Purpose
Pediatric Disorder, Vitamin D Deficiency, Retinal Disease
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Vitamin D deficiency
Sponsored by
About this trial
This is an interventional prevention trial for Pediatric Disorder
Eligibility Criteria
Inclusion Criteria:(Group 1):
- age <18 years old
- serum vitamin D [(25(OH) D), calcitriol] level <20 ngr/mL in previous two weeks
- visual acuity >20/20
- manifest refraction spherical equivalent <3D
- normal biomicroscopic and fundus examination.
Exclusion Criteria:
- history of any chronic ocular diseases, except for refractive error (e.g., uveitis, glaucoma, retinopathy of prematurity)
- history of ocular surgery (e.g., cataract, strabismus, open globe injury, laser photocoagulation)
- having an ocular abnormality (e.g., persistent fetal vasculature, optic disc hypoplasia, fovea plana)
- history of systemic diseases that have the potential to affect ocular tissues (e.g., diabetes mellitus, Graves' disease, albinism, Down syndrome, Fabry diseases, Wilson syndrome)
- history of any systemic diseases that can affect the serum vitamin D level (e.g., parathormone or calcium metabolism disorders)
- already receiving vitamin D treatment.
Sites / Locations
- Adıyaman U
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Pediatric endocrinologist
Ophthalmologist
Arm Description
Patient selection by pediatric endocrinologist on the basis of vitamin D
Evaluation of the results by 2 different retina specialists during the examination of patients Interpretation of the results without knowing the vitamin D level of patients
Outcomes
Primary Outcome Measures
choroidal thickness
subfoveal, and subfoveal 1500-µm- and 3000-µm-diameter distance nasal and temporal areas
retinal nerve fiber layer
Retinal nerve fiber layer will be detected by optical coherence tomography
The central retinal artery and vein calibers
The central retinal artery and vein calibers will be analyzed with the Interactive Vessel Analyzer
Secondary Outcome Measures
blood vitamin D levels
vitamin D deficiency or normal effects of vitamin D deficiency
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04891211
Brief Title
Retinal Changes in Vitamin D Deficiency
Acronym
VDD
Official Title
Evaluation of Retinal Structure in Pediatric Subjects With Vitamin D Deficiency
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
February 12, 2021 (Actual)
Primary Completion Date
March 1, 2021 (Actual)
Study Completion Date
March 10, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Adiyaman University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Retinal tissue parameters of pediatric patients with vitamin D deficiency will be evaluated in this prospective case-control study. The patients will be divided into 2 groups according to the vitamin D level. Retinal vessel diameters, retinal nerve fiber evaluation, choroidal thickness will be evaluated. Choroidal thinning decrease in retinal artery diameter and increase in retinal vein diameter will be detected in the vitamin D deficiency group.
Detailed Description
The study of the relationship between vitamin D status and retinal diseases is a new concept, and there is a large gap in research focusing on the pediatric population in the literature. The importance of vitamin D in retinal maturation and its role in the development of retinal diseases at a young age is being investigated. In this sense, as far as known, it is the first study investigating retinal structure parameters in pediatric patients with vitamin D deficiency.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Disorder, Vitamin D Deficiency, Retinal Disease, Choroidal Disease, Optic Nerve Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Group 1: 1) age <18 years old; 2) serum vitamin D [(25(OH) D), calcitriol] level <20 ngr/mL in previous two weeks Group 2: 1) age <18 years old; 2) serum vitamin D [(25(OH) D), calcitriol] level >20 ngr/mL in previous two weeks
Masking
InvestigatorOutcomes Assessor
Masking Description
Patients will be examined without knowing their vitamin D level. The OCT evaluations will be performed by a highly trained ophthalmic technician, and the compatibility of the results will be confirmed by two experienced retinal specialists.
Allocation
Randomized
Enrollment
150 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pediatric endocrinologist
Arm Type
Active Comparator
Arm Description
Patient selection by pediatric endocrinologist on the basis of vitamin D
Arm Title
Ophthalmologist
Arm Type
No Intervention
Arm Description
Evaluation of the results by 2 different retina specialists during the examination of patients
Interpretation of the results without knowing the vitamin D level of patients
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D deficiency
Intervention Description
Ocular significance of vitamin D deficiency in pediatric cases
Primary Outcome Measure Information:
Title
choroidal thickness
Description
subfoveal, and subfoveal 1500-µm- and 3000-µm-diameter distance nasal and temporal areas
Time Frame
up to 3 months
Title
retinal nerve fiber layer
Description
Retinal nerve fiber layer will be detected by optical coherence tomography
Time Frame
up to 3 months
Title
The central retinal artery and vein calibers
Description
The central retinal artery and vein calibers will be analyzed with the Interactive Vessel Analyzer
Time Frame
up to 3 months
Secondary Outcome Measure Information:
Title
blood vitamin D levels
Description
vitamin D deficiency or normal effects of vitamin D deficiency
Time Frame
up to 3 months
10. Eligibility
Sex
All
Gender Based
Yes
Gender Eligibility Description
Pediatrics population
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:(Group 1):
age <18 years old
serum vitamin D [(25(OH) D), calcitriol] level <20 ngr/mL in previous two weeks
visual acuity >20/20
manifest refraction spherical equivalent <3D
normal biomicroscopic and fundus examination.
Exclusion Criteria:
history of any chronic ocular diseases, except for refractive error (e.g., uveitis, glaucoma, retinopathy of prematurity)
history of ocular surgery (e.g., cataract, strabismus, open globe injury, laser photocoagulation)
having an ocular abnormality (e.g., persistent fetal vasculature, optic disc hypoplasia, fovea plana)
history of systemic diseases that have the potential to affect ocular tissues (e.g., diabetes mellitus, Graves' disease, albinism, Down syndrome, Fabry diseases, Wilson syndrome)
history of any systemic diseases that can affect the serum vitamin D level (e.g., parathormone or calcium metabolism disorders)
already receiving vitamin D treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emre Aydemir, M.D.
Organizational Affiliation
Adiyaman University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Adıyaman U
City
Adıyaman
State/Province
None Selected
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Participants will be told what the plan provided and how it worked. Information will be given about when he will participate in the study and the measurements to be taken for the study.
It will be emphasized that there was nothing that harmed the participants in the examinations.
IPD Sharing Time Frame
Participants will be examined at same times of the day in order not to affect the measurement results.
IPD Sharing Access Criteria
Participants will be divided into groups according to their vitamin D levels
Citations:
PubMed Identifier
23936865
Citation
Poon M, Craig ME, Kaur H, Cusumano J, Sasongko MB, Wong TY, Donaghue KC. Vitamin D deficiency is not associated with changes in retinal geometric parameters in young people with type 1 diabetes. J Diabetes Res. 2013;2013:280691. doi: 10.1155/2013/280691. Epub 2013 Jul 7.
Results Reference
result
Learn more about this trial
Retinal Changes in Vitamin D Deficiency
We'll reach out to this number within 24 hrs